Aegon Ltd. (AGN) Earnings Call Transcript
May 16, 2024
Earnings Call Speaker Segments
Good day, and thank you for standing by. Welcome to Aegon's First Quarter 2024 Trading Update Call. [Operator Instructions] Please note that today's conference is being recorded. I would now like to hand the conference over to your speaker, Yves Cormier, Head of Investor Relations. Please go ahead.
Thank you, operator, and good morning, everyone. Thank you for joining this conference call on our first quarter 2024 trading update. My name is Yves Cormier, Head of Investor Relations. Joining me today are Aegon's CEO, Lard Friese; and CFO, Matt Rider, to take you through our results. After that, we will continue with a Q&A session. But before we start, we would like you to -- we would like to ask you to read our disclaimer on forward-looking statements, which you can find at the back of the presentation. And now I would like to give the floor to Lard.
Yes. Thank you, Yves, and good morning, everyone, and thank you for joining us today. I will start today's presentation by running you through our strategic and commercial developments before handing over to Matt to address our first quarter results in more detail. So let's all move to Slide #2 to review the highlights of the quarter. The beginning of the year was marked by continued commercial momentum in the U.S. and Brazil as well as net inflows at our asset manager. In the first quarter of the year, we reported EUR 256 million of operating capital generation and included seasonally higher mortality in the U.S. We remain on track to meet our guidance of around EUR 1.1 billion for 2024. The capital ratios of our main units in the U.S. and the U.K. remain healthy and well above their respective operating levels. Furthermore, cash capital at the holding amounts to EUR 2 billion, well above the operating level, despite making good progress executing the EUR 1.5 billion share buyback program. At the end of last week, we have completed 92% of this program. As we indicated earlier, we expect to complete the share buyback program by the end of June. Today, we are announcing a planned new share buyback program of EUR 200 million, which we expect to start at the beginning of July and to complete by the end of 2024. Commercially, the first quarter of 2024 saw Aegon maintain commercial momentum. The U.K. Workplace business and our business in Brazil are performing well, and we recorded net deposits in both segments of our asset manager. At the same time, we continue to see challenges in our U.K. Retail business. U.S. business again performed well. We continue to execute on our strategy to transform Transamerica into America's leading middle-market life insurance and retirement company while continuing to reduce exposure to financial assets. Before discussing commercial results, I would like to address the changes we have made to segment reporting in order to better reflect Transamerica's strategy and business model on Slide #3. We have decided to regroup Transamerica's businesses from 2 to 4 business segments that are fully aligned with our strategy. To reflect the importance of the World Financial Group, or WFG, for our strategy, we have created the Distribution business segment. The business segment Savings & Investments includes the asset-based businesses, retirement plans, mutual funds and stable value solutions. The third strategic assets business segment is Protection Solutions, which consists of the insurance products, including indexed annuities. This is a central focus area for further growth in the U.S. middle market. Finally, all Financial Assets have now been grouped together in one reporting segment. This includes variable annuities, fixed annuities, including single premium group annuities, the legacy universal life book and long-term care. This resegmentation provides more transparency on our growth areas while presenting the results of Financial Assets separately. Finally, the new business segments also take into account the applicable IFRS accounting standards with the insurance businesses included in Protection Solutions and Financial Assets and the noninsurance businesses grouped into Distribution and Savings & Investments. Let's move now to Slide #4 to discuss the recent commercial performance. Starting WFG, our ambition is to increase the number of WFG agents to 110,000 by 2027 while, at the same time, improving agent productivity. We remain on track with the number of licensed agents increasing by 13% compared with the end of March last year to 76,000. Agent productivity also continues to improve, thanks to the measures WFG has taken. The number of multiticket agents, which are agents selling more than one life policy over the last 12 months, increased by 12% compared with a year ago. Within the Savings & Investments segment, let me zoom in on our progress in midsized retirement plans. Here, net deposits amounted to $1.2 billion in the first quarter of 2024, an increase compared with the same period of last year. Net deposits in the reporting period were amplified by a large pooled plan sale that we wrote in the first quarter of last year. In this segment, we also recorded continued growth in ancillary products such as the general accounts stable value product as well as the individual retirement accounts. In each of these products now, $11 of assets are invested by our customers. In the Protection Solutions segment, we are investing in both product manufacturing capabilities and in the operating model in order to position the individual life insurance business for further growth. New life sales increased by 5%, largely driven by higher indexed universal life sales, partially offset by lower traditional life sales. WFG represented 71% of total Transamerica individual life sales in this quarter. And we continue to write this business with attractive IRRs in excess of 12%. So let's move now to the United Kingdom on Slide #5. In the U.K. Workplace channel, we continue to see solid levels of inflows driven by new schemes and net deposits on existing schemes. Net deposits in the first quarter of 2024 amounted to GBP 546 million and were slightly lower than the same period last year due to outflows related to the exit of a single low-margin scheme. In the Retail channel, we continue to see net outflows as investor sentiment across the industry remains weak due to the macroeconomic environment. Annualized revenues loss and net deposits amounted to GBP 5 million over the reporting period, and this was driven by the gradual runoff of the traditional product portfolio and the net outflows in the Retail channel. Combined, these more than offset the revenues gained on net deposits in the Workplace channel. On Slide #6, I want to address the progress of the international segment with our joint ventures in China, Brazil and the Iberian Peninsula as well as the TLB businesses in Singapore and Hong Kong. New life sales decreased by 15% compared with the first quarter of 2024. While we recorded continued good growth in Brazil, this was more than offset by weaker sales in China and Spain. Nonlife new premium production decreased by 12%, with weaker demand in Spain. Operating capital generation in the international segment decreased by 23%, reflecting asset mix changes in China. So let's turn to Slide #7 to comment on our Asset Management business. The Global Platforms business reported net deposits of EUR 2.6 billion in the first quarter of 2024, returning to positive net deposits after recurring net outflows over the last 2 years. Strong fund performance and a large contract win in our U.K. fixed income business drove that result. We also recorded good inflows in alternative fixed income products, one of our focus areas. In addition, the Global Platforms segment is benefiting from the asset management partnership with ASR. In the Strategic Partnerships segment, we also recorded positive net deposits over the reporting period amounting to EUR 2.1 billion. This was especially driven by our Chinese joint venture, AIFMC, in part due to a successful collaboration with the consumer finance platform for our money market fund. Operating capital generation increased by EUR 26 million compared with the first quarter of 2023 to EUR 43 million in the first quarter of this year. This was a result of higher earnings especially in AIFMC, our Chinese asset manager, which benefited from a onetime expense item. I will now hand over to Matt to discuss the financial performance of Aegon in more detail, which starts on Slide #8.
Thank you, Lard, and good morning, everyone. Let me start with an overview of our financial performance over the last quarter on Slide 9. I want to start with operating capital generation before holding funding and operating expenses, which amounted to EUR 256 million in the first quarter of 2024. This is 12% lower than the same quarter of last year, mainly reflecting a onetime benefit in the release of required capital in the prior year period. Free cash flow amounted to EUR 14 million during the reporting period, driven by remittances from our international business. Cash capital at the holding stood at EUR 2 billion at the end of March 2024. The decrease compared with the balance at year-end 2023 was almost fully explained by the progress made during the period on the EUR 1.5 billion share buyback program. Gross financial leverage was largely unchanged at EUR 5.1 billion and remains at our target level of around EUR 5 billion. On Slide 10, I want to talk about the capital ratios of our main operating units. U.S. RBC ratio increased by 9 percentage points compared to the end of 2023 to 441% and remains well above the operating level of 400%. Operating capital generation and market movements each contributed 6 percentage points to the ratio and more than offset a remittance from an operating company to an intermediate holding company. The favorable impact of market movements was primarily due to good equity markets. The solvency ratio of Scottish Equitable, our main legal entity in the U.K., increased 192% and is above the operating level. This reflects the positive impact from operating capital generation and some smaller favorable onetime items. Let's now turn to Slide 11 to address operating capital generation in more detail. In the first quarter of 2024, operating capital generation before holding funding and operating expenses amounted to EUR 256 million, a decrease of 12% compared with the prior year period. Lower operating capital generation in the U.S. and international businesses was partly offset by an increase in Asset Management. Earnings on in-force decreased by 5%. Adverse underwriting experience in the U.K. and higher mortality in the U.S. were partly offset by onetime expense benefits in Asset Management and at Transamerica. The release of required capital was 25% lower following a onetime capital release in the U.S. in the first quarter of 2023. New business strain increased by 9%, higher new business strain in the U.S. as a consequence of higher sales in individual life and retirement plans. This was more than offset by lower levels of new business strain in the U.K. due to the impact of the sale of the protection book to Royal London and in China due to lower sales. With EUR 256 million of operating capital generation from the units, reflecting seasonal mortality in the U.S., we are on track to meet our guidance for 2024 of around EUR 1.1 billion. [Audio Gap]
of Aegon has many chapters, and we are just at the beginning of the next chapter to lead -- to create leading businesses in investment, protection and retirement solutions. [Audio Gap]
Average or expected new business stream of about $16 million during the course of the quarter. So those are the puts and takes. You also have to take into account that some differences within the other businesses in Asset Management, as Lard had mentioned, we did have a onetime good-guy expense thing in the AIFMC Chinese joint venture of about EUR 17 million. And then we had some bad guys in China, mainly in international of around EUR 9 million. If you do all the puts and takes here to get to a clean run rate of about EUR 280 million, which puts us on track to get to the EUR 1.1 billion by the end of the year.
And is it in force for Financial Assets?
Yes, Financial Assets are just going to be choppy. I mean you are going to get that from time to time, and there are various variances that are coming in. But in general, we're looking at OCG guidance for the Financial Assets of around EUR 200 million a year through kind of 2027.
And your next question comes from the line of David Barma, Bank of America.
The first one is just a follow-up on OCG. So you're now tracking fairly in line with your yearly target. I would have expected higher equity markets, higher reinvestment rates, maybe a faster buyout in universal life as well to all be supportive this year and more supportive than we thought in the middle of last year. So is there any reason that all of these items shouldn't help you outperform the EUR 1.1 billion target? I'm aware that the new business strain is going up, but is that the only factor offsetting the benefits -- the positive items? And then secondly, I have a question on Distribution risk in the U.S., please. So we had a pickup in market concerns over insurance agent distribution practices in the last few months. So could you share your thoughts in this context about the -- such risks for WFG, please?
Yes, David. I'll take the second one first, and then we'll go to your OCG. So I'll talk about the Distribution. We're very pleased that we have -- WFG has a very strong and well status Distribution franchise as we aim to grow into the segment of middle-market America, so middle-market retail households. And this is particularly the area where the 76,000 agents are focused on. It is a well-established sales force with licensed agents with strong compliance processes in place and practices in place. So we are very pleased to have -- I'm proud to have that capability to underpin the growth that we aim to achieve in the life insurance business. Matt?
Yes. With respect to the market movements. So what I gave you before was sort of what's a clean run rate for the first quarter of the year, and it works out to be about EUR 280 million. But what you've got going on is you had equity markets in the U.S. up about 10% in the first quarter of the year. So that's going to bode -- we've got a little bit of tailwind behind us for performance throughout the balance of the year. And you might think something on the order of maybe EUR 50 million round numbers for the benefit of that for the remainder of the year. So maybe back -- bake a little bit of that into your forecast, but it really depends on what equity markets do for the balance of the year. It still gets you to, again, around EUR 1.1 billion, but you can do the math on it.
And Lard, can I just follow up on the first point? There's also -- also linked to Distribution but slightly different. There's a -- there could be a new set of fiduciary standards coming into force later in the year for retirement products. What would be the implication for Transamerica if that were to come through?
So you're talking about the Department of Labor fiduciary rule of -- and that's what it's -- how is it called, the -- in colloquial language? Well, first of all, we are all in favor of appropriate -- an effective regulation around the price. At the same time, we also believe that regulation needs to always be balanced to ensure there's proper access that clients can have to good advice. And this rule, it's a 500-page document. So we're still trailing through it and try to fully understand it. But where we are taken as we stand today is that we are very well positioned to deal with this. We already have quite extensive practices in place and documentation practices in place. So we need to adapt here and there some documentation and some processes. But nothing that we believe will have a material impact on our ongoing business or on our Distribution company. I do want to remind you of one thing though, David. I don't know to what extent you're familiar with that. Something similar was introduced in 2016 and was subsequently, in court, thrown out. And what we are observing since this rule came out a couple of weeks ago, 10 days ago, is that, indeed, a legal action like we saw in 2016 is -- has started to commence already. So we also need to evaluate whether -- depending on how that goes, whether this rule, if and when and how this rule be indeed implemented. Let's put it that way.
And your next question comes from the line of Farooq Hanif from JPMorgan.
I just want to say congratulations to both Matt and Duncan, please. But just 2 questions. Firstly, on the STOLI, the institutionally owned life policies, will there be an ambition to go beyond the 40% if you think there's appetite for this? And what are your views on that? And the second question is on the choice of EUR 200 million. Is it just a number that you think is appropriate to get down to your cash target? Or what was the thought process around EUR 200 million specifically?
Let me take -- will you first [ comment ] the STOLI? [indiscernible] in a second.
So a brief recap. So we set that ambition, 40% of the targeted policies, the $7 billion face amount by the end of 2027, but we're already sitting at 34%, which is really good, right? So we had invested about $700 million into the program. Currently, we've been able to recycle a lot of that. So we've actually been able to purchase contracts worth about $1.2 billion so far. So I would say it all depends on pricing. 40% is a -- it's a good ambition. We'll look at it as we go forward. We want to make sure that we get the good returns that we're expecting out of this before we get ahead of our skis here. So for right now, we're going to keep the 40% target out there. We'll see what the market gives us, and we could go beyond that maybe, but right now, we're just making good progress.
Yes, and Farooq, very kind of you. Your congratulations to Duncan and to Matt are well received. Thank you. On the share buyback, well, it derives from our capital management framework. Simply put, if there is surplus cash capital beyond what we need to execute on the transformation as a company and if we cannot invest it in value-creating opportunities, then we will return it to shareholders in the most efficient form. This is our capital management mantra since the beginning of my tenure here. And we are, as you know, in the market with a EUR 1.5 billion buyback. We are at the tail end of that. We still need to do a little bit, but it's going to be finished before the summer. We are above the target operating range for our cash position. And so it's very -- and we've observed that it's very likely that our cash position will still be above the range. So we said, okay, we evaluated it and said that we're announcing a new buyback program today of EUR 200 million, which we will complete by the end of -- until -- before the end of this year.
And may I just ask and I'll understand if you don't answer this, but what the nature of your conversations with ASR about how they would like to progress going forward. So I mean what would your preferred option be if ASR decided, for example, to start a certain share buyback program?
We -- well, first of all, I'm on the Board of ASR. So any discussions that take place there is something that I think is not appropriate for me to comment on. But I don't know whether you're pertaining to the stake itself or what about any other comments around ASR and its own policies around this is something that I leave to [ us ].
[Operator Instructions] And your next question comes from the line of Michael Huttner from Berenberg.
Just like Farooq said, congratulations, Matt and -- on a very successful performance and also to Duncan to make it to CFO. I had to, just like the others -- Protection Solutions, you seem to stress that a couple of times in growth. Can you say if you're looking at deals and what kind of deals, what's your thinking there? And then I'll go back to the question, which was about the operating capital generation, but I assume it more broadly. Normally, when have a quarter, you kind of raise guidance of this target or that target or the -- one of the many targets you have. This time, you haven't raised any single target, which is -- I think it's -- that's actually a one-off. Is there something in the background which is running more slowly or you're more worried or you kind of think, well, actually Duncan can take the glory when it happens? [ That'd ] be understood.
I see 2 gentlemen with a smile on their face, so thank you for congratulating them. And frankly, from my personal perspective, as you know, I know both gentlemen for a very long period of time, and I couldn't have wished for a more flawless transition quite frankly. So when it comes to protection and solutions, this is the segment that encompasses, in the U.S., the life insurance and annuity business. We are growing that now a number of quarters, already quite pronounced. And in this quarter, you could see an additional kind of growth continuing. That is, of course, largely powered by our efforts to grow the licensed -- the professional sales agency that we have, which has now increased to 76,000 agents. We are aiming to do a couple of things here: increase the number to 110,000 in North America; number two, increasing the number of agents that sell multiple tickets; and increasing, as a result, the overall growth of the platform. By the way, it may be good to note that when you want to evaluate the strength and the power of that platform, there's 2 things as you need to look at, which is -- in the future, which is the Protection Solutions segment, which picks up the earnings on the manufacturing of the product; and then the Distribution segment, which will now highlight the earnings that we are making as a distributor as well. So I think it's important to combine the 2 to appreciate the full attractiveness of that business. Separately, we're also, of course, having other Distribution channels in WFG, and we're focusing our efforts on that as well to continue to grow and make sure that, in the annuity and life insurance product lines, that we progress further. When it comes to the OCG, Matt?
Yes, Michael, I wouldn't read anything into this. It is the first quarter of the year. We're just off to a -- sorry, we just set the guidance out there in the fourth quarter. So no, we're not changing the guidance on the operating capital generation. Although I would say that perhaps the EUR 200 million share buyback was partly unexpected in the first quarter. So we're maintaining, I think, good momentum on the capital generation side and, obviously, returning capital to shareholders. So I think we're still in pretty good shape here. And by the way, Michael, thanks. And Farooq, thanks for your kind words. I really do appreciate it.
May I have a follow-up or not? The follow-up is really simply, did you look at the Manulife deal with RGA? And is it something you could do?
That's what you're referring to, Michael. Well, when it comes to M&A, we're looking -- I mean, yes, we have taken note of that transaction. We actually try to follow the market in general on the transaction that's happening. But of course, the #1 focus that we have is on improving our businesses and being very disciplined capital allocators to make sure that we create value for stockholders. But if we see opportunities that present themselves, then it's always where opportunity meets discipline. And where I look -- what we're always evaluating is very strict financial and nonfinancial criteria, things like does it fix strategy, does it -- are we ready to integrate and operationally ready to extract the value that it creates, and will it really create value for our stockholders. So focused on operating our businesses organically, being very disciplined allocators of capital but looking at opportunities when they arise, but we will evaluate those against very strict financial and nonfinancial criteria.
And your next question comes from the line of Nasib Ahmed from UBS.
So first of all, I mean, similar to the other, thanks, Matt, for all your help over the years, and congratulations, Duncan on the new role. Two questions, first on WFG. I'm trying to dig a little bit deeper on the responses. Firstly, if you look at the NAIC data on the company complaints index, TPLIC and TLIC, they're 2x, 5x the average. Is that something that you track, something that we should be tracking, something that you're trying to get down in terms of the number of complaints that you've got there? And then on WFG, in terms of the contracts that the agents have with WFG, I think there's 2 types of contracts that are typically signed with agents in the U.S. Is WFG -- does it have both types of contracts, one or the other? Those are my 2 questions.
Yes, Nasib, thank you very much. When it comes to complaint -- I don't quite understand what you're referring to. When it comes to complaints, of course, we register complaints and look at them across our businesses and also in the United States. And if you're asking about the complaints and how they evolved vis-à-vis WFG and other Distribution channels that we use, in fact, we're seeing, on a relative basis, that the complaints we're getting through the different Distribution channels are low actually for WFG. So if you compare for our agents, it's a very large agency sales force. But if I could compare on a relative basis, the number of complaints we're receiving from clients from WFG vis-à-vis other channels, it's actually relatively low. So that's one thing to bear in mind. And yes, we do track, of course, those things very carefully alongside many other things that we do. The second point is about the contract. So WFG is an insurance agency. They are independent contractors that signed an agency agreement with WFG. They are not WFG employees. They work -- by the way, we are not a closed shop. It's an open architecture platform. So it means that they are selling our products, but they're also selling products from many other insurance companies. So I think it's important to note that as well. I guess that's what I can say on these contracts, and that's how it works.
Perfect. Sorry, if I can clarify the first question, I was more talking about the complaints data against insurance companies by NAIC. I think there's a company complaints index, where you've got both TLIC and TPLIC there. I'm not sure if that's something that you track or you're trying to get done?
I think these are service-level details. Is that correct, what you're talking about? I think that's what [indiscernible] monetary first here. But let's take this off-line. We do measure the service levels, obviously, through all our channels. And as I said, where it pertains to complaints with WFG operation, complaints are relatively low.
And your next question comes from the line of Jason Kalamboussis from ING.
Yes. I have to also congratulate both Duncan for his new role, Matt for his outstanding, really, help over the years and also Lard for the continuity transition. So I have a couple of quick questions for me. The one is, why are you the best owner of WFG, if you can remind me? Why do you need to own it? And a bit of a separate question. I mean, when you look at primary, it's trading at a p of 13x. They are at low because of the bare ARPU. So wouldn't it make sense at some stage to consider even if you think you're the best owner that maybe at the end of the day, trading at such a higher multiple, you would be -- you would have a benefit that eventually decide to separate? And the other thing was on the share buyback. I can see that there are things that you have to answer, but I'm coming back to the question that Farooq asked. You did announce, I mean, so much like you are preempting and you're announcing a EUR 200 million share buyback. You could have easily done that in August, where eventually the EUR 1.5 billion have ended. What makes you a bit reluctant at this stage to actually do in August, for example, to have done an announcement for the full 12 months and also to reduce a bit the stake just at least to give an indication that that's the direction? So we're not looking for any significant reduction, but you could have done a small one just to indicate the direction. If you could comment on that one, it would be great.
Yes, Jason, thank you for your questions. And again, thank you very much for your kind words to Matt and to Duncan. Let's start with the discussion around ASR. We're happy holders of the company's stock. I mean the stake allows us to benefit from, from our regard, a unique synergy potential that this combination brings. So -- and this stake does not have a definite time frame. We have said, and we're consistent in that and we maintain that view that in principle, we will hold the stake until the ASR share price reflects the intrinsic value or until value-creating opportunities present themselves that require the capital. So we're happy holders of the stock. And we've been consistently saying that let's not forget that the integration process of the combination is at the early stage of it given time. So again, we're happy holders of the stock. When it comes to the share buyback, well, this is pretty simple, actually. As I said before, we have a stated capital management policy. We take that policy seriously as we have demonstrated multiple times throughout the years. And we're nearly done with the tail end of the EUR 1.5 billion buyback, so that will be done before the summer. We looked at the cash capital position, which is nearly EUR 2 billion right now. We said the total -- announcement that we did justifies that we stay true to our capital management policy. And as a result, we launched the buyback now and not in the half year. That's basically -- that's -- we didn't see was necessary to wait until the half year. That's what I would like to say about that. Then on the WFG franchise, we are, as I said, very pleased with -- and privileged to be the owner of this business. And it is absolutely critical to our company's objective. Transamerica aims to become -- to transform itself into the leading life insurance and retirement company for middle America, middle America retail households. And this is an underserved market of 68 million households in the United States with a massive opportunity, and we are privileged to have such a large capability in that area that will allow us to fulfill our strategic objective with Transamerica. And the progress that we're showing over the last couple of quarters is that we are progressing very well in our growth. So we're very pleased to have it. Now the good news is also that given the segmentation that we are now going to do, you will have more visibility on the power of this platform. It is not only -- we're not only generating value by manufacturing life insurance products and sell that through that massive Distribution platform, but also the Distribution platform is selling products from other companies, and that generates Distribution income for us. And what you can see over the full year 2023 is that the total earnings involved were 161 million. So this is coming from a base of 37 million in 2020, so think a little bit about this and try to -- Jason, so in 2020, the earnings that we had at that time were 37 million. In 2023, that's under the 61 million. And let's not forget we're growing that franchise, and we're selling more product through that franchise. So we will -- we believe that the new segmentation will allow you to evaluate the progress that we're making there and appreciate the value of this franchise as a whole. So we believe we're a great owners of this. It's actually core to our mission of Transamerica's growth in the United States. So we're pleased with that platform.
And your next question is a follow-up from David Barma from Bank of America.
I have 2 small ones. One, just coming back on M&A. And I appreciate your comment, Lard, about strict financial discipline. But would you be able to talk a little bit about what you see as strategic for Aegon today when thinking about M&A? Is it more Distribution capabilities? Is it books of retirement plan assets? Is it wealth management or asset management? Are you able to talk a little bit about your preference in terms of business lines, please?
Core markets. I mean let me be simple about this. When we look at -- we have been very clear about the markets that we focus on. So when we talk about potential M&A opportunity, we would evaluate that to strengthen and accelerate our strategies in core markets. Sorry, you have maybe another question, right?
Yes. Secondly, on new business strain. I don't know if I'm missing something on this, but just can you remind us where the -- what's driving the new business strain increase? Did the sales in individual life plans seem to have picked up that much in Q1? And maybe more broadly, if you could just give us a bit of color on what product lines are you're particularly excited about for this year in terms of sales activity?
On the exact detail of the business strain, we're going to ask Matt. But let me take you a little bit the product lines that we believe -- that we're focusing on because we believe they're very attractive. So in the U.S., it's again, our indexed universal life product is making returns with an -- IRR is above 12%. So it's a profitable product line that we are growing and expanding, especially through the WFG franchise but also other Distribution channel. Then we look at annuities, especially what we call registered index-linked annuity, which is a particular form of annuities that provide kind of a buffer on the downside while capping the upside, if you will. So these are structured products. They're not annuities with high interest rate-sensitive guarantees, but it is an annuity line that has a big demand in the U.S. marketplace that we're capturing -- capitalizing upon that demand well. Then on the retirement side, in the U.S., it is retirement plans where we particularly focus on the middle market, so medium-sized plans and pooled plans. There's not many companies that have really the capability to also run plans in a pooled format in the U.S. We are one of those that are known for it. And therefore, we are capitalizing upon that opportunity. But obviously, if we can do a deal in the large market that is profitable and that we can get good fees for, then we will also participate in that. What we're also focusing very much on is the participants in these pension plans in the U.S., where through ancillary products, stable value solutions, particularly in IRAs, particularly we -- which are now $11 billion each. We aim to grow the profitability per plan participants. That is something that we're focusing on. Then outside of the U.S., it's really -- Brazil has been -- I keep reminding everybody, Brazil has been a business for us that, over the many years, has a consistent track record of double-digit growth, profitable growth in protection life insurance products. The Workplace business in the U.K. is continuing to see very strong momentum. I think we're now #3 in flows, #4 in the market as a whole. And I would say the Asset Management business is getting a reversal of momentum. We had our first bad year -- bad half year, in the first half year 2023 that you saw in the back end of 2023 flows coming back, and that persisted in the first quarter. But it's these kinds of product lines -- and I can go on, if you will, but these kinds of product lines that really believe that we're aiming to allocate a lot of resources in time and effort to increase our Distribution progress and also increase the overall volumes. Matt, on new business strain.
Yes. For the U.S., new business strain was $192 million for the quarter, which is somewhat above our -- what we've guided for of about like $175 million for the quarter, but we're getting it in areas that we like. So we're basically getting in the individual life insurance protection business, and we typically have a little bit higher new business strain in the first quarter of the year. So we're getting it in that area. We like that. We're still able to maintain our pricing margins north of 12%. And then the other area that we like is the retirement plans business, where part of the big strategy for the U.S. business is to grow in what Lard called as the ancillary businesses. General Account Stable Value is one. It's basically a bank account that savers can use for retirement plans. But that, we expect that to grow. And indeed, we have grown that about 8% from the prior year quarter to about $11.3 billion. And because we are growing that, then it does require additional capital for that. But again, these are good things. This is very much according to plan.
We have time for one further question. And we will now take the last question for today. And the question comes from the line of Michael Huttner from Berenberg.
On U.S. mortality, so seasonality in Q1 may be a touch higher than maybe the normal run rate. Can you give us your feeling about mortality going forward? And here, I think there are 2 strands. I thought one maybe less volatility because you bought back a big chunk of that institutional portfolio. But also what I heard from a client 2 days ago, what about the new wonder drug from Novo Nordisk? Does it mean there's suddenly mortality, people live longer now?
Yes, let me pick that one up. So indeed, we did have unfavorable mortality in the quarter. It's largely -- it's seasonality, mostly. It did not come by the way from institutionally owned contracts where the -- or, let's say, the life insurance contracts and the Financial Assets. It was just more from traditional -- our traditional portfolio and a little bit in the variable universal life portfolio. I would call this normal claims fluctuation. Your specific question was around what do we expect in the future, and that's really kind of anybody's guess. As we come out of COVID, we still expect to see maybe elevated mortality. People have not sought care during COVID. Perhaps we're going to see some elevated claims for a period of time. But honestly, this is really just claims volatility in the first quarter, mainly due to seasonality. As to the wonder drug, given my impending retirement here, I certainly hope so. But I don't know about the -- but I don't know, obviously, for sure.
I will now hand the call back to Yves Cormier for closing remarks.
Thank you, operator. This concludes today's Q&A session. Should you have any remaining questions, please get in touch with us in Investor Relations. On behalf of Lard and Matt, I want to thank you for your attention. Thanks again, and have a good day.
Thank you. This concludes today's conference call. Thank you for participating. You may now disconnect.
Read the full transcript via the API
You're viewing the first half of this call. Get the complete Aegon Ltd. transcript - plus 252,000+ transcripts from 12,000+ companies, speaker segments and full-text search - through the EarningsAPI REST API or hosted MCP server.
Get an API key View API docs →For developers and AI pipelines
Programmatic access to Aegon Ltd. earnings transcripts and 252,000+ others is available through the
EarningsAPI REST API and the hosted MCP server.
Quarterly plans from $105 - full transcripts, speaker segments, full-text search,
and the /api/v1/transcripts/recent polling endpoint for ETL pipelines.